<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=551791532206281&amp;ev=PageView&amp;noscript=1">
On-Demand Webinar

A Clinical Discussion on the Current State of PE Workflow

Webinar_hero-1 (2)
 
 
Given the range of symptoms that present when a patient has a sudden blockage of one or more pulmonary arteries, quickly diagnosing and treating pulmonary embolism continues to be a challenge. But new ways of organizing teams – and connecting them through technology – promise hope.
 
In this live panel discussion, leaders in the field of PE care share their experience and learning from their efforts to advance care team processes and improve patient outcomes.
PErevolution

TOPICS COVERED IN THIS SESSION:

  • What’s working and what’s not in PE diagnosis and care
  • Where and how pulmonary embolism care can be coordinated and streamlined 
  • Pitfalls to avoid and learning to leverage for your facility
  • Live Q&A 

SPEAKERS

Ken Rosenfield, MD

Ken Rosenfield, MD

Massachusetts General Hospital
Interventional Cardiology & Vascular Medicine
Keith Sterling, MD

Keith Sterling, MD

Inova Health System
Interventional Radiology & Diagnostic Radiology
Vic Tapson, MD

Vic Tapson, MD

Cedars Sinai Medical Center
Internal Medicine & Pulmonary Medicine

MODERATOR

James Benenati, MD

James Benenati, MD

Chief Medical Officer, Penumbra, Inc.

VIEW THE WEBINAR

 

 

Penumbra and RapidAI are working together to develop clinical and workflow solutions for pulmonary embolism to streamline triage and decision-making. Penumbra, Inc., is a global healthcare company focused on innovative therapies. Penumbra designs, develops, manufactures and markets novel products and has a broad portfolio that addresses challenging medical conditions. RapidAI is the global leader in using AI to combat life-threatening vascular and neurovascular conditions. From home to hospital and ER to OR, RapidAI is leading the next evolution of clinical decision-making and patient workflow, bringing the end-to-end patient journey into focus.